![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 38, 29717-29723, September 22, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the This study was designed to investigate whether
angiotensin II induces the interleukin (IL)-6 family of cytokines in
cardiac fibroblasts and, if so, whether these cytokines can augment
cardiac hypertrophy. Angiotensin II increased IL-6, leukemia inhibitory factor (LIF) and cardiotrophin-1 mRNA by 6.5-, 10.2-, and 2.0-fold, respectively, but did not affect IL-11, ciliary neurotrophic factor, or
oncostatin M in cardiac fibroblasts. Enzyme-linked immunosorbent assay
revealed that angiotensin II-stimulated conditioned medium from cardiac
fibroblasts contained 9.3 ng/ml IL-6 at 24 h, which was 24-fold
higher than the control. It phosphorylated gp130 and STAT3 in
cardiomyocytes, which was reduced with RX435 (anti-gp130 blocking
antibody). It increased [3H]phenylalanine uptake
and cell area by 44% and 86% in cardiomyocytes compared with mock
medium. RX435 suppressed these increases by 26% and 38%, while TAK044
(endothelin-A/B-R blocker) suppressed them by 52% and 52%,
respectively. Antisense oligonucleotides against LIF and
cardiotrophin-1 blocked their up-regulation, and attenuated the
conditioned medium-induced increase in [3H]phenylalanine
uptake by 21% and 13%, respectively. The combination of antisense
oligonucleotides to LIF and cardiotrophin-1 decreased their uptake by
33%. These results indicated that angiotensin II induced IL-6, LIF,
and cardiotrophin-1 in cardiac fibroblasts, and that these cytokines,
particularly LIF and cardiotrophin-1, activated gp130-linked signaling
and contributed to angiotensin II-induced cardiomyocyte hypertrophy.
Interleukin-6 Family of Cytokines Mediate Angiotensin II-induced
Cardiac Hypertrophy in Rodent Cardiomyocytes*
,
§,
,
,
,
,
, and
Cardiopulmonary Division, Department of
Internal Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo
160-8582 and ¶ Chugai Pharmaceutical Co. Ltd., 1-135 Komakado,
Gotenba, Shizuoka 412-8513, Japan
*
This work was supported in part by Research Grant
JSPS-RFTF97I00201 from the Research for the Future Program of the Japan Society for the Promotion of Science, and by research grants from the
Ministry of Education, Science and Culture, Japan, Health Science
Research Grants for Advanced Medical Technology from the Ministry of
Welfare, Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
C. Natal, M. A. Fortuno, P. Restituto, A. Bazan, I. Colina, J. Diez, and N. Varo Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E52 - E60. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lopez, J. M. Castellano, A. Gonzalez, J. Barba, and J. Diez Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension Hypertension, November 1, 2007; 50(5): 977 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy Physiol Genomics, October 19, 2007; 31(2): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lopez, N. Varo, J. Diez, and M. A. Fortuno Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? Cardiovasc Res, August 1, 2007; 75(3): 536 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Baudino, W. Carver, W. Giles, and T. K. Borg Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1015 - H1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwata, R. T. Cowling, D. Gurantz, C. Moore, S. Zhang, J. X.-J. Yuan, and B. H. Greenberg Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2356 - H2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Petersen, K. A. Krumholz, and B. A. Burleigh Toll-Like Receptor 2 Regulates Interleukin-1{beta}-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi Infect. Immun., October 1, 2005; 73(10): 6974 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Pemberton, S. D. Raudsepp, T. G. Yandle, V. A. Cameron, and A. M. Richards Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch Cardiovasc Res, October 1, 2005; 68(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tomita, K. Matsumura, Y. Wakamatsu, Y. Matsuzaki, I. Shibuya, H. Kawaguchi, M. Ieda, S. Kanakubo, T. Shimazaki, S. Ogawa, et al. Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart J. Cell Biol., September 26, 2005; 170(7): 1135 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zolk, S. Engmann, F. Munzel, and R. Krajcik Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1214 - E1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Freund, R. Schmidt-Ullrich, A. Baurand, S. Dunger, W. Schneider, P. Loser, A. El-Jamali, R. Dietz, C. Scheidereit, and M. W. Bergmann Requirement of Nuclear Factor-{kappa}B in Angiotensin II- and Isoproterenol-Induced Cardiac Hypertrophy In Vivo Circulation, May 10, 2005; 111(18): 2319 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Freed, R. H. Cunnington, A. L. Dangerfield, J. S. Sutton, and I. M.C. Dixon Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart Cardiovasc Res, March 1, 2005; 65(4): 782 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fairweather, S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, S. J.L. Gatewood, D. B. Njoku, and N. R. Rose Interferon-{gamma} Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-{beta}1, Interleukin-1{beta}, and Interleukin-4 in the Heart Am. J. Pathol., December 1, 2004; 165(6): 1883 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. Leite, C. Fleming, J. S. Pollock, R. C. Webb, and M. W. Brands Hypertensive Response to Acute Stress Is Attenuated in Interleukin-6 Knockout Mice Hypertension, September 1, 2004; 44(3): 259 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Rebsamen, E. Perrier, C. Gerber-Wicht, J.-P. Benitah, and U. Lang Direct and Indirect Effects of Aldosterone on Cyclooxygenase-2 and Interleukin-6 Expression in Rat Cardiac Cells in Culture and after Myocardial Infarction Endocrinology, July 1, 2004; 145(7): 3135 - 3142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Skurk, V. van Harmelen, and H. Hauner Angiotensin II Stimulates the Release of Interleukin-6 and Interleukin-8 From Cultured Human Adipocytes by Activation of NF-{kappa}B Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1199 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, T. Shioi, K. Uchiyama, T. Miyamoto, S. Sasayama, and A. Matsumori Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ancey, E. Menet, P. Corbi, S. Fredj, M. Garcia, C. Rucker-Martin, J. Bescond, F. Morel, J. Wijdenes, J.-C. Lecron, et al. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation Cardiovasc Res, July 1, 2003; 59(1): 78 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yin, P. Li, M. Zheng, L. Chen, Q. Xu, K. Chen, Y.-y. Wang, Y.-y. Zhang, and C. Han Interleukin-6 Family of Cytokines Mediates Isoproterenol-induced Delayed STAT3 Activation in Mouse Heart J. Biol. Chem., May 30, 2003; 278(23): 21070 - 21075. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Gonzalez-Cabrera, R. J. Gaivin, J. Yun, S. A. Ross, R. S. Papay, D. F. McCune, B. R. Rorabaugh, and D. M. Perez Genetic Profiling of alpha 1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130 Mol. Pharmacol., May 1, 2003; 63(5): 1104 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Manabe, T. Shindo, and R. Nagai Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Circ. Res., December 13, 2002; 91(12): 1103 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M.C. Dixon A new altruist on the block: effects of adrenomedullin after myocardial infarction Cardiovasc Res, December 1, 2002; 56(3): 347 - 349. [Full Text] [PDF] |
||||
![]() |
M. R. Bristow and C. S. Long Cardiotrophin-1 in Heart Failure Circulation, September 17, 2002; 106(12): 1430 - 1432. [Full Text] [PDF] |
||||
![]() |
W. Briest Do we have a new early marker of chronic transplant dysfunction now? Cardiovasc Res, June 1, 2002; 54(3): 492 - 494. [Full Text] [PDF] |
||||
![]() |
G. Plenz, H. Eschert, M. Erren, T. Wichter, M. Bohm, M. Flesch, H. H. Scheld, and M. C. Deng The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1508 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuruda, M. Jougasaki, G. Boerrigter, B. K. Huntley, H. H. Chen, A. B. D'Assoro, S. C. Lee, A. M. Larsen, A. Cataliotti, and J. C. Burnett Jr Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor Circ. Res., February 8, 2002; 90(2): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor Circ. Res., February 8, 2002; 90(2): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Fujii, T. Matsumoto, T. Yamamoto, et al. Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1485 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Choi, H. M. Ko, J.-W. Kim, H.-K. Lee, S. S. Han, S.-B. Chun, and S. Y. Im Platelet-Activating Factor-Induced Early Activation of NF-{{kappa}}B Plays a Crucial Role for Organ Clearance of Candida albicans J. Immunol., April 15, 2001; 166(8): 5139 - 5144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. H. Ng, C. S. Long, and M. A. Bogoyevitch A Role for the Extracellular Signal-regulated Kinase and p38 Mitogen-activated Protein Kinases in Interleukin-1beta -stimulated Delayed Signal Tranducer and Activator of Transcription 3 Activation, Atrial Natriuretic Factor Expression, and Cardiac Myocyte Morphology J. Biol. Chem., July 27, 2001; 276(31): 29490 - 29498. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuruda, M. Jougasaki, G. Boerrigter, B. K. Huntley, H. H. Chen, A. B. D'Assoro, S. C. Lee, A. M. Larsen, A. Cataliotti, and J. C. Burnett Jr Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor Circ. Res., February 8, 2002; 90(2): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor Circ. Res., February 8, 2002; 90(2): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sano, K. Fukuda, T. Sato, H. Kawaguchi, M. Suematsu, S. Matsuda, S. Koyasu, H. Matsui, K. Yamauchi-Takihara, M. Harada, et al. ERK and p38 MAPK, but not NF-{kappa}B, Are Critically Involved in Reactive Oxygen Species-Mediated Induction of IL-6 by Angiotensin II in Cardiac Fibroblasts Circ. Res., October 12, 2001; 89(8): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |